Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.
Lugo-Palacios, DG; BIDULKA, P; O'NEILL, S; CARROLL, O; Basu, A; Adler, A; DíazOrdaz, K; BRIGGS, A; GRIEVE, R;
2024
Health economics, (2024).34 1 10.1002/hec.4903.
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.
Ko, M; Frivold, C; Mvundura, M; Soble, A; Gregory, C; Christiansen, H; Hasso-Agopsowicz, M; FU, H; Jit, M; Hsu, S; Mistilis, JJ; Scarna, T; Earle, K; Menozzi-Arnaud, M; Giersing, B; Jarrahian, C; Yakubu, A; Malvolti, S; Amorij, J-P;
2024
Vaccines, (2024).12 9 10.3390/vaccines12091075.
Examining sustained sub-national health system development: experience from the Western Cape Province, South Africa, 1994-2016.
GILSON, L; Vallabhjee, K; Naledi, T; Brady, L; Hawkridge, A; Pienaar, D; Schneider, H;
2024
Health policy and planning, (2024).39 10 10.1093/heapol/czae090.
Why did England change its law on deceased organ donation in 2019? The dynamic interplay between evidence and values.
Williams, L; Bostock, J; Noyes, J; McLaughlin, L; O'NEILL, S; AL-HABOUBI, M; BOADU, P; MAYS, N;
2024
Health economics, policy, and law, (2024).19 3 10.1017/S1744133124000112.
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].
HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; Jit, M; ATKINS, KE;
2024
The Lancet regional health. Europe, (2024).45, 10.1016/j.lanepe.2024.101073.
Evaluation 1 of "Water Treatment and Child Mortality: A Meta-analysis and Cost-effectiveness Analysis".
WADDINGTON, HS; Masset, E;
2024
The unjournal (2024). 10.21428/d28e8e57.c4f3e6dd/8e1d77b1.
Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada.
SUN, L; WEI, X; Fierheller, CT; Dawson, L; Oxley, S; Kalra, A; Sia, J; Feldman, F; Peacock, S; Schrader, KA; LEGOOD, R; Kwon, JS; Manchanda, R;
2024
JAMA network open, (2024).7 9 10.1001/jamanetworkopen.2024.32725.
Effectiveness and impact of monovalent rotavirus vaccination in Afghanistan: a test-negative case-control analysis.
ANWARI, P; Burnett, E; Safi, N; Samsor, A; Safi, H; Chavers, TP; Parashar, UD; CLARK, AD; Tate, JE;
2024
The Lancet. Global health, (2024).12 9 10.1016/S2214-109X(24)00237-7.
Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study.
CHEN, C; Ang, G; Akksilp, K; Koh, J; SCOTT, JA G; CLARK, A; Jit, M;
2024
The Lancet. Global health, (2024).12 9 10.1016/S2214-109X(24)00232-8.
Qualitative system dynamics modelling to support the design and implementation of tuberculosis infection prevention and control measures in South African primary healthcare facilities.
Diaconu, K; Karat, A; BOZZANI, F; MCCREESH, N; Falconer, J; Voce, A; VASSALL, A; GRANT, AD; Kielmann, K;
2024
Health policy and planning, (2024).39 10 10.1093/heapol/czae084.